The role of bevacizumab in recurrent glioblastoma: new insights from randomized trials

by Franceschi, Enrico, Brandes, Alba A
Published in CNS Oncol (2015)

CNS Oncology: reflecting a rapidly changing landscape

by Friedman, Henry S, Brandes, Alba A
Published in CNS Oncol (2012)

Cardiovascular Safety of VEGF-Targeting Therapies: Current Evidence and Handling Strategies

by Girardi, Fabio, Franceschi, Enrico, Brandes, Alba A.
Published 2010

The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) crit...

by Lanese, Andrea, Franceschi, Enrico, Brandes, Alba A.
Published in Oncol Ther (2018)

Practical Management of Bevacizumab-Related Toxicities in Glioblastoma

by Brandes, Alba A., Bartolotti, Marco, Tosoni, Alicia, Poggi, Rosalba, Franceschi, Enrico
Published in Oncologist (2015)

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology

by Brandes, Alba A., Tosoni, Alicia, Spagnolli, Federica, Frezza, Giampiero, Leonardi, Marco, Calbucci, Fabio, Franceschi, Enrico
Published 2008

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas

by Maggio, Ilaria, Franceschi, Enrico, Tosoni, Alicia, Nunno, Vincenzo Di, Gatto, Lidia, Lodi, Raffaele, Brandes, Alba A
Published in CNS Oncol (2021)

Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma

by Brandes, Alba A., Nicolardi, Linda, Tosoni, Alicia, Gardiman, Marina, Iuzzolino, Paolo, Ghimenton, Claudio, Reni, Michele, Rotilio, Antonino, Sotti, Guido, Ermani, Mario
Published 2006

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma

by Schiffgens, Salveena, Wilkens, Ludwig, Brandes, Alba A., Meier, Tatiana, Franceschi, Enrico, Ermani, Mario, Hartmann, Christian, Sandalcioglu, Ibrahim Erol, Dumitru, Claudia A.
Published in Oncotarget (2016)

Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1(105GGT)) in brain tumors of a cohort of Italian patients

by Acquaviva, Giorgia, Visani, Michela, de Biase, Dario, Marucci, Gianluca, Franceschi, Enrico, Tosoni, Alicia, Brandes, Alba A., Rhoden, Kerry J., Pession, Annalisa, Tallini, Giovanni
Published in Sci Rep (2018)

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Ne...

by Brandes, Alba A., Tosoni, A., Franceschi, E., Blatt, V., Santoro, A., Faedi, M., Amistà, P., Gardiman, M., Labianca, R., Bianchini, C., Ermani, M., Reni, M.
Published 2009

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

by Franceschi, Enrico, Stupp, Roger, van den Bent, Martin J., van Herpen, Carla, Laigle Donadey, Florence, Gorlia, Thierry, Hegi, Monika, Lhermitte, Benoit, Strauss, Lewis C., Allgeier, Anouk, Lacombe, Denis, Brandes, Alba A.
Published 2012

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

by Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Caserta, Claudia, Fabi, Alessandra, Clavarezza, Matteo, Maiello, Evaristo, Eoli, Marica, Lombardi, Giuseppe, Monteforte, Marta, Proietti, Emanuela, Agati, Raffaele, Eusebi, Vincenzo, Franceschi, Enrico
Published in Neuro Oncol (2016)

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

by Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Fabi, Alessandra, Caserta, Claudia, Tosoni, Alicia, Eoli, Marica, Lombardi, Giuseppe, Clavarezza, Matteo, Paccapelo, Alexandro, Bartolini, Stefania, Cirillo, Luigi, Agati, Raffaele, Franceschi, Enrico
Published in Oncotarget (2017)

Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy

by Brandes, Alba A, Ardizzoni, Andrea, Artioli, Fabrizio, Cappuzzo, Federico, Cavanna, Luigi, Frassineti, Giovanni Luca, Frassoldati, Antonio, Leonardi, Francesco, Longo, Giuseppe, Maestri, Antonio, Tassinari, Davide, Franceschi, Enrico, Nunno, Vincenzo Di, Pinto, Carmine
Published in Future Oncol (2020)

AT-18 SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NE...

by Cloughesy, Tim, Wick, Wolfgang, Mason, Warren, Henriksson, Roger, Saran, Frank, Nishikawa, Ryo, Carpentier, Antoine F., Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana, Brandes, Alba A., Revil, Cedric, Abrey, Lauren, Chinot, Olivier L.
Published 2014

The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma

by de Biase, Dario, Genestreti, Giovenzio, Visani, Michela, Acquaviva, Giorgia, Di Battista, Monica, Cavallo, Giovanna, Paccapelo, Alexandro, Cancellieri, Alessandra, Trisolini, Rocco, Degli Esposti, Roberta, Bartolini, Stefania, Pession, Annalisa, Tallini, Giovanni, Brandes, Alba A.
Published in PLoS One (2017)

Rare Primary Central Nervous System Tumors in Adults: An Overview

by Franceschi, Enrico, Frappaz, Didier, Rudà, Roberta, Hau, Peter, Preusser, Matthias, Houillier, Caroline, Lombardi, Giuseppe, Asioli, Sofia, Dehais, Caroline, Bielle, Franck, Di Nunno, Vincenzo, van den Bent, Martin, Brandes, Alba A., Idbaih, Ahmed
Published in Front Oncol (2020)

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer

by Passardi, Alessandro, Scarpi, Emanuela, Cavanna, Luigi, Dall'Agata, Monia, Tassinari, Davide, Leo, Silvana, Bernardini, Ilaria, Gelsomino, Fabio, Tamberi, Stefano, Brandes, Alba A., Tenti, Elena, Vespignani, Roberto, Frassineti, Giovanni L., Amadori, Dino, De Giorgi, Ugo
Published in Oncotarget (2016)

Molecular alterations in pancreatic tumors

by Visani, Michela, Acquaviva, Giorgia, De Leo, Antonio, Sanza, Viviana, Merlo, Lidia, Maloberti, Thais, Brandes, Alba A, Franceschi, Enrico, Di Battista, Monica, Masetti, Michele, Jovine, Elio, Fiorino, Sirio, Pession, Annalisa, Tallini, Giovanni, de Biase, Dario
Published in World J Gastroenterol (2021)